Tetracycline-induced steatosis in primary canine hepatocyte cultures

Fundamental and Applied Toxicology

Volumn 40, Issue 2, 1997, Pages 256-263

  Amacher, David E ^a   Martin, Barbara Anne ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRACYCLINE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOLOGY; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; LIVER CELL CULTURE; LIVER METABOLISM; MALE; MICROSCOPY; MITOCHONDRIAL RESPIRATION; NONHUMAN; STEATOSIS;

ANIMALIA; CANIS FAMILIARIS;

EID: 85033532182     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1997.2389     Document Type: Article

References (28)

1. Alpers D. H., Isselbacher K. J. Fatty liver: Biochemical and clinical aspects. Diseases of the Liver. 1975;Lippincott, Philadelphia. p. 815-832.
2. Amacher D. E., Kenny C. V., Fasulo L. M., Schomaker S. J., Smolarek T. A. Biotransformation and cytotoxicity of tetrahydroaminoacridine in cultured mammalian hepatocytes. In Vitro Toxicol. 10:1997;183-193.
3. Breen K. J., Schenker S., Heimberg M. Fatty liver induced by tetracycline in the rat. Dose-response relationships and effect of sex. Gastroenterology. 69:1975;714-723.
4. Butterworth B. E., Ashby J., Bemudez E., Casciano D., Mirsalis J., Probst G., Williams G. A protocol and guide for the in vitro rat hepatocyte DNA-repair assay. Mutat. Res. 189:1987;113-121.
5. Deboyser D., Goethals F., Krack G., Roberfroid M. Investigation into the mechanism of tetracycline-induced steatosis: Study in isolated hepatocytes. Toxicol. Appl. Pharmacol. 97:1989;473-479.
6. Du Buy H. G., Showacre J. L. Selective localization of tetracycline in mitochondria of living cells. Science. 133:1961;196-197.
7. Enat R., Jefferson D. M., Ruiz-Opazo, Gatmaitan Z, Leinwand L. A., Reid L. M. Hepatocyte proliferation in vitro: Its dependence on the use of serum-free hormonally defined medium and substrata or extracellular matrix. Proc. Natl. Acad. Sci. USA. 81:1984;1411-1415.
8. Estler C.-J., Bocker R. Role of sex and age in the tetracycline-induced hepatic steatosis. I. Comparative study on the effect of rolitetetracycline on some parameters of hepatic lipid metabolism in male and female mice. Toxicol. Appl. Pharmacol. 54:1980;508-513.
9. Folch J., Lees M., Stanley S. A simple method for the isolation and purification of total lipides form animal tissues. J. Biol. Chem. 226:1957;497-509.
10. Freneaux E., Labbe G., Letteron P., Le Dinh T., Degott C., Geneve J., Larrey D., Pessayre D. Inhibition of mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic. Hepatology. 8:1988;1056-1062.
11. Fromenty B., Fisch C., Labbe G., Degott C., Deschamps D., Berson A., Letteron P., Pessayre D. Amiodarone inhibits mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis in the liver of mice. J. Pharmacol. Exp. Ther. 255:1990;1371-1376.
12. Fromenty B., Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67:1995;101-154.
13. Geneve J., Hayat-Bonan B., Labbe C., Letterone P., Freneaux E., Le Dinh T., Larrey D., Pessayre D. Inhibition of mitochondrial β-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug. J. Pharmacol. Exp. Ther. 242:1987;1133-1137.
14. Greenspan P., Mayer E. P., Fowler S. D. Nile red: A selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100:1985;965-973.
15. Kivman G. Y., Gulyaev A. E., Nadirova B. A. Intracellular distribution of tetracyclines in hepatocytes of rats. Antibiotiki. 28:1983;834-837.
16. Lazarow P. B. Assay of peroxisomal β-oxidation of fatty acids. Lowenstein J. M. Methods in Enzymology. 1981;315-319 Academic Press, New York.
17. Le Bricquir Y., Larrey D., Blanc P., Pageaux G. P., Michel H. Tianeptine - An instance of drug-induced hepatotoxicity predicted by prospective experimental studies. J. Hepatol. 21:1994;771-773.
18. Lepper M. H., Wolfe C. K., Zimmerman H. J., Caldwell E. R., Spies H. W., Dowling H. F. Effects of high doses of Aureomycin on human liver. Arch. Intern. Med. 88:1951;271-283.
19. Letteron P., Fromenty B., Terris B., Degott C., Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J. Hepatol. 24:1996;200-208.
20. Lewis M., Schenker S., Combes B. Studies on the pathogenesis of tetracycline-induced fatty liver. Am. J. Dig. Dis. 12:1967;429-438.
21. Loscher W., Wahnschaffe U., Honack D., Drews E., Nau H. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting. Epilepsy Res. 16:1993;183-194.
22. Noda S., Haratake J., Sasaki A., Ishii N., Umezaki H., Horie A. Acute encephalopathy with hepatic steatosis induced by pantothenic acid antagonist, calcium hopantentate, in dogs. Liver. 11:1991;134-142.
23. Ramirez-Zacarias J. L., Castro-Munozledo F., Kuri-Harcuch W. Quantitation of adipose tissue conversion and triglycerides by staining intracytoplasmic lipids with Oil Red O. Histochemistry. 97:1992;493-497.
24. Reddy J. K., Lalwani N. D. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol. 12:1983;1-58.
25. Seglen P. O. Preparation of isolated rat liver cells. Methods Cell Biol. 13:1976;29-83.
26. Schach von Wittenau M., Delahunt C. S. The distribution of tetracyclines in tissues of dogs after repeated oral administration. J. Pharmacol. Exp. Ther. 152:1996;164-169.
27. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6:1969;24-27.
28. Zimmerman H. J. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. 1978;Appleton-Century-Crofts, New York.